The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them.
The drug Abilify MyCite, developed by Otsuka Pharmaceutical Co. Ltd, was first approved by the FDA in 2002 to treat schizophrenia. The ingestible sensor, made by Proteus Digital health, was approved for marketing in 2012.
Food and Drug Administration (FDA)- approved 1st drug in the United States with a digital ingestion tracking system- named Abilify MyCite– developed by Otsuka Pharmaceutical Co. Ltd.
Static/Current Takeaway Points Important for IBPS PO Mains 2017 Exam-
- US President- Donald Trump (45th)
Source- The Hindu